Date: 20–22 April 2022
Venue: Manchester Central, Manchester, UK
TP01 Withdrawn
TP03 Impact of the COVID-19 pandemic on HIV consultations in England
TP04 The impact of deferred monitoring in people living with HIV during the COVID-19 pandemic
TP05 Serological responses to SARS-CoV2 vaccination in people with HIV: The SCAPE-HIV Study
P001 Two years experience with doravirine
P006 Long acting lenacapavir in people with multi-drug resistant HIV-1: Week 52 results
P011 B/F/TAF five-year outcomes in treatment-naïve adults
P012 Real life experience of Doravirine in a large multi-centre HIV service
P013 Real world data of people living with HIV-2: experience of 7 London clinics
P014 Real world data of doravirine usage: efficacy and safety outcomes in a large urban HIV service
P016 Antiretroviral regimen simplification for individuals receiving maraviroc
P017 Impact of treatment adherence on efficacy of dolutegravir + lamivudine and dolutegravir + tenofovir disoproxil fumarate/emtricitabine: pooled week 144 analysis of the GEMINI-1 and GEMINI-2 clinical studies
P018 Three versus four drug regimens for people with high and very high viral loads
P019 Dolutegravir/Lamivudine efficacy outcomes in people living with HIV with or without resistance results: 48-week pooled analysis
P020 Efficacy and safety outcomes by BMI category over 48 weeks in phase 3/3b cabotegravir and rilpivirine long-acting trials
P022 Anti-retroviral therapy modification in an acute setting
P023 Effectiveness and tolerability of the 2-drug regimen dolutegravir plus lamivudine in people with HIV-1: a systematic literature review of real-world evidence from clinical practice
P024 Treatment-emergent resistance to bictegravir with minimal risk factors
P026 People living with HIV have higher frequencies of circulating endothelial colony-forming cells: steps towards patient-specific models to evaluate cardiovascular risk
P027 Towards a prophylactic HIV vaccine: fine needle aspiration reveals cellular features of human lymph nodes compared with blood in the EAVI2020_01 study
P028 Effective CD4 count restoration linked to SARS-CoV-2 seroconversion following BNT162b2 mRNA SARS-CoV-2 vaccine in people living with HIV (PLWH) – a case report
P029 Increasing HPV vaccination uptake in PLWHIV: the need to improve both clinician training and patient health promotion
P032 Terrence Higgins Trust and NHS Greater Glasgow & Clyde HIV testing campaign
P034 Outcomes of a national complex HIV pre-exposure prophylaxis (PrEP) multi-disciplinary meeting
P035 Barriers of PrEP use among people who recently acquired HIV: qualitative study. Findings from the SHARE (Surveillance of HIV Acquired Recently) initiative
P036 Psycho-social factors affecting treatment compliance: The need for a patient-centred approach
P039 Confinement : Women, HIV And Pregnancy During The Covid-19 Pandemic In The UK
P042 Pregnancy outcomes of women conceiving on ART at a London HIV clinic 2015-2020
P043 Withdrawn
P044 Cervical screening and HPV testing in young women living with perinatally acquired HIV: An interim assessment of the SHiP study
P045 Lipid disorders in HIV patients and impact on raised HDL cholesterol level
P046 Prognostic relevance of lymphocyte-CRP-ratio and CRP-albumin-ratio as markers of inflammation in hospitalised adults with HIV
P047 Assessing health-related quality of life in people with HIV and cognitive issues
P048 Inflammatory conditions necessitating immunosuppression in a cohort of young adults with perinatally acquired HIV: A case series
P050 Metabolic health of young adults with perinatally acquired HIV – an unknown need?
P051 Spotlight on British South Asians living with HIV
P054 Patient-reported outcomes after switching to a 2-drug regimen of fixed-dose combination dolutegravir/lamivudine: 48-week results from the SALSA study
P055 Weight change in youth on tenofovir alafenamide (TAF)
P057 The assessment of hepatic fibrosis and steatosis using transient elastography in youth with perinatal HIV
P058 SARS-CoV2 vaccination acceptance in people with HIV
P059 Hyper-eosinophilic syndrome with neurological and gastrointestinal involvement in a patient living with HIV
P061 Physical inactivity and associated health factors among patients attending an urban UK HIV and sexual health clinic: a secondary analysis of a clinic-based cross-sectional survey
P062 SARS-CoV-2 antibody seroprevalence in a large HIV clinic cohort
P063 Management of active tuberculosis in people living with HIV in a tertiary centre
P064 COVID infection and vaccination in a semi-rural HIV cohort
P065 Unexpected HIV Viral load rises in a COVID pandemic
P066 Missed opportunities for diagnosing HIV in primary care
P067 Offering mass HIV blood testing to Primary Care patients via (MJog) Text Message: What we learnt and did it work?
P068 Introducing routine HIV testing to a gastroenterology ward: a junior doctor-led project
P069 A re-audit of late diagnosed HIV positive individuals in 2016 and 2019 in Greater Manchester
P072 Improving blood-borne pathogen (BBP) testing on an adult inpatient mental health ward
P073 Measuring progress towards ending HIV transmission in England in the COVID-19 pandemic era
P075 A whole systems approach to improving HIV testing in UK General Practice
P076 HIV Testing in Indicator Conditions: Knowledge and Confidence in Primary Care
P078 Regimens and outcomes for people with HIV and known hepatitis B core antibody positivity
P081 Screening positive for depression is associated with poor self-reported adherence to antiretroviral therapy among people living with HIV attending a sexual health and HIV clinic in the UK
P082 Life Really Changed: Challenging people’s perceptions of what it’s like to live with HIV
P083 Developing a model of dating for young adult women living with HIV
P084 Wellbeing of Black African women over 50 living with HIV
P085 Medicine-related burden in people living with HIV
P086 Stigma related to HIV pre-exposure prophylaxis use among men who have sex with men in Wales: a mixed methods study
P088 Ageing with HIV and co-morbidities: Exploring the social constructs of ageing and NCDs in the context of HIV in Zambia
P089 “The stigma being with HIV and double stigma being black”: experiences and needs of racially minoritised people living with HIV
P090 Understanding the perceived therapeutic need and value associated with novel long-acting antiretroviral regimens among people living with HIV in 12 European countries
P092 Characteristics and outcomes of domestic abuse (DA) in people living with HIV (PLWH)
P093 A review of the management of people living with HIV in long-term residential/nursing care in a greater London cohort
P094 Improving U=U discussions with people living with HIV: an audit of practice in an infectious diseases clinic
P096 Interest in, and feasibility of, a genital Herpes Simplex Virus Type-2 infection vaccine study in a cohort of people living with HIV
P097 Implementing a menopausal service for women living with HIV (WLWH)
P098 Preferences for the management of sexually transmitted infections in the South African health system: A discrete choice experiment
P099 Vaccine administration and monitoring in a regional HIV centre: a service evaluation
P100 Improving the quality of care for people living with HIV (PLWH) in Primary Care
P101 HIV care during Covid: Learning from patients’ experiences
P102 Reduced monitoring in a stable patient pathway: Patients’ perspective and co-design
P103 Have HIV inpatient and outpatient care become disconnected?
P104 'Zero HIV’: a primary care population-based project to increase HIV diagnosis and improve engagement of patients living with HIV
P105 A quality improvement project to increase the uptake of Human Papilloma Virus vaccine for HIV+ women aged <40
P107 Patient and clinician experience of video and telephone appointments (VATA) vs face-to-face appointments (FTFA) in a large urban HIV service
P108 The experiences of individuals living with HIV in Ireland attending for out-patient physiotherapy
P111 From engagement to co-production: London’s Improvement Collaborative as a model for partnership between clinical and community-based services
P113 Challenging Glasgow’s HIV outbreak through support, prevention and care: an evaluation of Waverley Care’s HIV Street Support Project
P114 General population understanding and self-reported attitudes towards people living with HIV
P115 Improving access to hepatitis C treatment in people living with HIV
P118 The ePrEP Clinic: developing a clinical consultation for online PrEP provision
P120 Identifying factors associated with low COVID-19 vaccination uptake in a diverse London HIV cohort